| Identification | Back Directory | [Name]
GSK143 | [CAS]
1240390-27-5 | [Synonyms]
GSK143
GSK143
(GSK-143
2-[[(3R,4R)-3-aminooxan-4-yl]amino]-4-(4-methylanilino)pyrimidine-5-carboxamide
5-Pyrimidinecarboxamide, 2-[[(3R,4R)-3-aminotetrahydro-2H-pyran-4-yl]amino]-4-[(4-methylphenyl)amino]- | [Molecular Formula]
C17H22N6O2 | [MDL Number]
MFCD28963898 | [MOL File]
1240390-27-5.mol | [Molecular Weight]
342.4 |
| Hazard Information | Back Directory | [Uses]
GSK 143 has pharmacological activity which is used in treatment of retinoblastoma protein (Rb)-positive cancers using kinase or BCL-2 inhibitors in combination with CDK4/6 inhibitors. |
|
|